Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-04 3:35 pm Purchase | 2024-12-31 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 7,574,330 9.900% | 2,998,945 (+65.55%) | Filing History |
| 2025-02-03 4:57 pm Purchase | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 7,472,745 9.900% | 502,320 (+7.21%) | Filing History |
| 2025-01-27 4:02 pm Purchase | 2024-12-23 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 6,659,993 9.900% | 3,896,525 (+141.00%) | Filing History |
| 2024-12-02 11:53 am Unchanged | 2024-11-12 | 13D | NeurAxis, Inc. NRXS | Rosalind Advisors Inc. | 2,100,840 9.900% | 0 (Unchanged) | Filing History |
| 2024-12-02 09:57 am Purchase | 2024-11-12 | 13G | NeurAxis, Inc. NRXS | Rosalind Advisors Inc. | 2,100,840 9.900% | 2,100,840 (New Position) | Filing History |
| 2024-11-15 10:33 am Unchanged | 2024-10-30 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 2,763,468 9.900% | 0 (Unchanged) | Filing History |
| 2024-11-14 9:46 pm Unchanged | 2024-10-30 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 2,763,468 9.900% | 0 (Unchanged) | Filing History |
| 2024-11-06 10:48 am Sale | 2024-10-31 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 7,196,776 6.900% | -675,713 (-8.58%) | Filing History |
| 2024-10-28 4:02 pm Unchanged | 2024-09-30 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 7,438,181 9.800% | 0 (Unchanged) | Filing History |
| 2024-10-23 3:14 pm Unchanged | 2024-09-30 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 7,872,489 8.900% | 0 (Unchanged) | Filing History |
| 2024-10-23 3:05 pm Unchanged | 2024-09-30 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 686,172 9.900% | 0 (Unchanged) | Filing History |
| 2024-10-23 2:57 pm Purchase | 2024-09-30 | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 628,050 5.800% | 114,560 (+22.31%) | Filing History |
| 2024-10-23 2:44 pm Sale | 2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI | Rosalind Advisors Inc. | 750,000 1.030% | -641,577 (-46.10%) | Filing History |
| 2024-10-23 2:26 pm Sale | 2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB | Rosalind Advisors Inc. | 0 0.000% | -1,508,419 (Position Closed) | Filing History |
| 2024-10-18 2:52 pm Purchase | 2024-09-30 | 13G | OptiNose, Inc. OPTN | Rosalind Advisors Inc. | 552,500 5.500% | 49,357 (+9.81%) | Filing History |
| 2024-10-18 2:21 pm Unchanged | 2024-09-30 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 4,575,385 9.900% | 0 (Unchanged) | Filing History |
| 2024-08-14 7:20 pm Purchase | 2024-08-06 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 686,172 9.900% | 686,172 (New Position) | Filing History |
| 2024-08-14 7:15 pm Purchase | 2024-07-25 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 6,970,425 9.900% | 2,977,839 (+74.58%) | Filing History |
| 2024-07-12 10:35 am Unchanged | 2024-06-28 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 4,575,385 9.900% | 0 (Unchanged) | Filing History |
| 2024-07-11 6:02 pm Unchanged | 2024-06-28 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 4,575,385 9.900% | 0 (Unchanged) | Filing History |